173 related articles for article (PubMed ID: 24948689)
41. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
[TBL] [Abstract][Full Text] [Related]
42. Depression in multiple sclerosis: a long-term longitudinal study.
Koch MW; Patten S; Berzins S; Zhornitsky S; Greenfield J; Wall W; Metz LM
Mult Scler; 2015 Jan; 21(1):76-82. PubMed ID: 24852924
[TBL] [Abstract][Full Text] [Related]
43. Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway.
Berg-Hansen P; Smestad C; Sandvik L; Harbo HF; Celius EG
Eur J Neurol; 2013 Dec; 20(12):1546-52. PubMed ID: 23834430
[TBL] [Abstract][Full Text] [Related]
44. Multiple sclerosis: clinical characteristics and disability progression in Moroccan children.
Ait Ben Haddou E; Alhyan M; Aasfara J; Regragui W; Ibrahimi A; Razine R; Abouqal R; Benomar A; Yahyaoui M
J Neurol Sci; 2014 Nov; 346(1-2):128-32. PubMed ID: 25216553
[TBL] [Abstract][Full Text] [Related]
45. The association between multiple sclerosis and uveitis.
Olsen TG; Frederiksen J
Surv Ophthalmol; 2017; 62(1):89-95. PubMed ID: 27491475
[TBL] [Abstract][Full Text] [Related]
46. Changes in the ascertainment of multiple sclerosis.
Marrie RA; Cutter G; Tyry T; Hadjimichael O; Campagnolo D; Vollmer T
Neurology; 2005 Oct; 65(7):1066-70. PubMed ID: 16217060
[TBL] [Abstract][Full Text] [Related]
47. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
[TBL] [Abstract][Full Text] [Related]
48. [Uvetitis and multiple sclerosis].
Sisková A; Ríhová E; Havrdová E
Cesk Slov Oftalmol; 2005 Jul; 61(4):235-44. PubMed ID: 16164091
[TBL] [Abstract][Full Text] [Related]
49. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
50. [Dynamics of clinical presentations of multiple sclerosis in Amur region for the period of 1960 to 2005].
Karnaukh VN
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):75-8. PubMed ID: 19891350
[TBL] [Abstract][Full Text] [Related]
51. Self-reported health promotion and disability progression in multiple sclerosis.
D'hooghe MB; Nagels G; De Keyser J; Haentjens P
J Neurol Sci; 2013 Feb; 325(1-2):120-6. PubMed ID: 23294496
[TBL] [Abstract][Full Text] [Related]
52. Predictors of relapse rate in MS clinical trials.
Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
[TBL] [Abstract][Full Text] [Related]
53. Selected aspects of the epidemiology of multiple sclerosis in Poland - a multicentre pilot study.
Kułakowska A; Bartosik-Psujek H; Hożejowski R; Mitosek-Szewczyk K; Drozdowski W; Stelmasiak Z
Neurol Neurochir Pol; 2010; 44(5):443-52. PubMed ID: 21082490
[TBL] [Abstract][Full Text] [Related]
54. Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
Raskin E; Achiron A; Zloto O; Neuman R; Vishnevskia-Dai V
PLoS One; 2022; 17(6):e0264918. PubMed ID: 35767533
[TBL] [Abstract][Full Text] [Related]
55. Effect of gender on late-onset multiple sclerosis.
Bove RM; Healy B; Augustine A; Musallam A; Gholipour T; Chitnis T
Mult Scler; 2012 Oct; 18(10):1472-9. PubMed ID: 22383227
[TBL] [Abstract][Full Text] [Related]
56. The onset of multiple sclerosis in Greece: a single-center study of 1,034 consecutive patients.
Koutsis G; Evangelopoulos ME; Andreadou E; Mandellos D; Karachalios G; Potagas C; Karantoni E; Karouli M; Chrysovitsanou C; Vassilopoulos D; Sfagos C
Eur Neurol; 2010; 63(6):350-6. PubMed ID: 20530965
[TBL] [Abstract][Full Text] [Related]
57. Multiple sclerosis in Australia: prognostic factors.
Hammond SR; McLeod JG; Macaskill P; English DR
J Clin Neurosci; 2000 Jan; 7(1):16-9. PubMed ID: 10847644
[TBL] [Abstract][Full Text] [Related]
58. Concomitant multiple sclerosis and another autoimmune disease: Does the clinical course change?
Sahraian MA; Owji M; Naser Moghadasi A
Clin Neurol Neurosurg; 2016 Nov; 150():92-95. PubMed ID: 27614222
[TBL] [Abstract][Full Text] [Related]
59. [Young-onset multiple sclerosis].
Silva A; Sá MJ
Rev Neurol; 1999 Jun 1-15; 28(11):1036-40. PubMed ID: 10390767
[TBL] [Abstract][Full Text] [Related]
60. Clinical characteristics of multiple sclerosis in Lebanon.
Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
